Home/ Supplements/ Omega 3/ Omega 3 Plus

Omega 3 Plus

product on market Softgel Capsule Indiana Botanic Gardens Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish oil and Coenzyme Q-10 are supported by strong evidence for promoting cardiovascular health and cellular energy production. However, the overall evidence coverage for this specific formulation is very limited. These ingredients are generally recognized as safe for most adults when taken as directed.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega 3 Plus
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (4% DV)
2 Gram(s)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)

Other Ingredients

Gelatin Capsule yellow Beeswax Soy Lecithin Rice Bran Oil Mixed Tocopherols
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take 2 softgels daily, preferably with meals, as a dietary supplement, or as directed by a physician.

Warnings & Precautions

Contains: Soy.

Warning: If you are taking any medications or are pregnant or nursing, do not use prior to consulting a physician.

For your protection, this container has an outer safety seal. (Do not accept if missing or broken.)

Keep out of reach of children

Formulation Notes

Contains: Soy.

Additional Information

Total health support

Dietary Support

Store at room temperature.

Metadata

Product Details

UPC / SKU7 03308 82086 7
DSLD Entry Date2017-08-22
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID77233
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.